Compare AbbVie Inc (ABBV) vs Etsy Inc (ETSY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Etsy Inc — how do they compare? AbbVie Inc trades at $253.47 (market cap $449.91B), while Etsy Inc trades at $76.72 (market cap $7.36B). The key difference: AbbVie Inc is far larger — about 61.1× Etsy Inc's market cap, and AbbVie Inc pays a 2.72% dividend while Etsy Inc pays none. Which is the better fit depends on your goals.
| ABBV | ETSY | |
|---|---|---|
Market Cap | $449.91B | $7.36B |
Sector | Health | Consumer Cyclical |
52-Week High | $261.07 | $79.66 |
52-Week Low | $184.85 | $44.05 |
Enterprise Value | $513.38B | $9.01B |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $253.61, down 0.45% on the day, with strong technical momentum showing bullish moving averages and key support at $253. The company reported Q1 2026 EPS of $2.65, beating expectations, while revenue growth is supported by Skyrizi and Rinvoq offsetting Humira declines. Analysts maintain a bullish consensus with 68% buy ratings and a $266.33 price target, representing 5% upside potential.
The outlook remains positive with robust immunology portfolio performance and dividend growth, though risks include patent cliffs in the 2030s and competitive pressures. Current valuation metrics appear elevated with P/E at 124.83, requiring sustained earnings growth to justify premium multiples. The stock offers income appeal with consistent dividend payments while navigating portfolio transition.
ETSY trades at $77.59, up 0.81% today, with a bullish technical signal from moving averages and support at $74. The company reported three consecutive quarterly earnings beats, with Q1 2026 EPS of $0.89 beating expectations of $0.62 (Seeking Alpha, 2026-05-29). Revenue for 2025 was $2.88B, though net income declined to $163M. Analyst consensus is a Buy with a $70.79 price target, and recent news highlights growth in AI seller tools and buyer recovery momentum.
ETSY shows potential with strong profitability margins and positive cash flow trends, but faces risks from high debt and competitive pressures. The stock's valuation multiples like P/E of 28.76 suggest moderate premium, while institutional sentiment remains cautiously optimistic amid execution challenges in sustaining growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
